XML 39 R2.htm IDEA: XBRL DOCUMENT v3.26.1
Pay vs Performance Disclosure - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Pay vs Performance Disclosure          
Pay vs Performance Disclosure, Table
Average Summary Compensation Table Total For Non-PEO NEOs(3)
($)
Average Compensation Actually Paid to Non-PEO NEOs(2)
($)
Value of Initial fixed $100 investment based on:(4)
Year
Summary Compensation Table Total for PEO(1)
($)
Compensation Actually Paid to PEO(2)
($)
Total
Shareholder Return
($)
Peer Group Total Shareholder
Return(5)
($)
Net Income(6)
($)
20259,607,508 3,476,201 3,338,774 (518,662)13.07122.97(644,759,000)
20248,499,587 1,906,523 6,047,431 4,949,046 21.6092.16(463,661,000)
20238,613,209 10,682,869 4,124,633 4,966,948 31.5092.69(328,066,000)
20226,315,903 (5,833,229)2,046,760 (4,631,734)24.6388.62(239,476,000)
2021673,591 21,789,135 647,815 13,678,688 54.7398.60(186,479,000)
        
Named Executive Officers, Footnote Christopher Gibson was our PEO for each year presented. The individuals comprising the non-PEO NEOs for 2025 were Najat Khan and Ben Taylor.
The individuals comprising the non-PEO NEOs for 2024 were Ben Taylor, Najat Khan, David Mauro, Tina Marriott, and Michael Secora.
The individuals comprising the non-PEO NEOs for 2023 were Tina Marriott, Michael Secora, David Mauro, and Shafique Virani.
The individuals comprising the non-PEO NEOs for 2022 were Tina Marriott, Michael Secora, Shafique Virani, and Ramona Doyle.
The individuals comprising the non-PEO NEOs for 2021 were Ramona Doyle and Shafique Virani. Although the proxy statement for our 2022 annual meeting of stockholders also identified Tina Marriott and Michael Secora as NEOs, Dr. Doyle and Dr. Virani were our actual non-PEO NEOs for fiscal 2021 because they were the two most highly compensated executive officers other than the PEO who were serving as executive officers at the end of fiscal 2021. 		       
Peer Group Issuers, Footnote The peer group used for this table is the Nasdaq Biotechnology Index (the “Index”), which we also utilize for the performance graph required by Item 201(e) of Regulation S-K included in our Annual Report for the year ended December 31, 2025.        
PEO Total Compensation Amount $ 9,607,508 $ 8,499,587 $ 8,613,209 $ 6,315,903 $ 673,591
PEO Actually Paid Compensation Amount $ 3,476,201 1,906,523 10,682,869 (5,833,229) 21,789,135
Adjustment To PEO Compensation, Footnote The amounts shown for “compensation actually paid” have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually earned, realized, or received by the PEO or other NEOs. The following table details the applicable adjustments that were made to determine “compensation actually paid”:
FY 2025
PEO
($)		Average Non-PEO NEOs
($)
Summary Compensation Table - Total Compensation9,607,508 3,338,774 
(Deduct) Grant Date Fair Value of Stock Awards and Option Awards Granted in Fiscal Year(8,655,000)(2,511,298)
(Increase) Fair Value at Fiscal Year End of Outstanding and Unvested Stock Awards and Option Awards Granted in Fiscal Year3,676,389 1,244,324 
(Increase/Deduct) Change in Fair Value of Outstanding and Unvested Stock Awards and Option Awards Granted in Prior Fiscal Years(1,939,821)(2,384,494)
(Increase) Fair Value at Vesting of Stock Awards and Option Awards Granted in Fiscal Year that Vested During Fiscal Year1,265,784 351,650 
(Increase/Deduct) Change in Fair Value as of Vesting Date of Stock Awards and Option Awards Granted in Prior Fiscal Years for which Applicable Vesting Conditions were Satisfied During Fiscal Year(478,659)(557,619)
(Deduct) Fair Value as of Prior Fiscal Year End of Stock Awards and Option Awards Granted in Prior Fiscal Years that Failed to Meet Applicable Vesting Conditions During Fiscal Year— — 
Compensation Actually Paid3,476,201 (518,662)
        
Non-PEO NEO Average Total Compensation Amount $ 3,338,774 6,047,431 4,124,633 2,046,760 647,815
Non-PEO NEO Average Compensation Actually Paid Amount $ (518,662) 4,949,046 4,966,948 (4,631,734) 13,678,688
Adjustment to Non-PEO NEO Compensation Footnote The amounts shown for “compensation actually paid” have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually earned, realized, or received by the PEO or other NEOs. The following table details the applicable adjustments that were made to determine “compensation actually paid”:
FY 2025
PEO
($)		Average Non-PEO NEOs
($)
Summary Compensation Table - Total Compensation9,607,508 3,338,774 
(Deduct) Grant Date Fair Value of Stock Awards and Option Awards Granted in Fiscal Year(8,655,000)(2,511,298)
(Increase) Fair Value at Fiscal Year End of Outstanding and Unvested Stock Awards and Option Awards Granted in Fiscal Year3,676,389 1,244,324 
(Increase/Deduct) Change in Fair Value of Outstanding and Unvested Stock Awards and Option Awards Granted in Prior Fiscal Years(1,939,821)(2,384,494)
(Increase) Fair Value at Vesting of Stock Awards and Option Awards Granted in Fiscal Year that Vested During Fiscal Year1,265,784 351,650 
(Increase/Deduct) Change in Fair Value as of Vesting Date of Stock Awards and Option Awards Granted in Prior Fiscal Years for which Applicable Vesting Conditions were Satisfied During Fiscal Year(478,659)(557,619)
(Deduct) Fair Value as of Prior Fiscal Year End of Stock Awards and Option Awards Granted in Prior Fiscal Years that Failed to Meet Applicable Vesting Conditions During Fiscal Year— — 
Compensation Actually Paid3,476,201 (518,662)
        
Compensation Actually Paid vs. Total Shareholder Return
The following chart sets forth the relationship between “compensation actually paid,” as calculated in accordance with Item 402(v) of Regulation S-K (“Compensation Actually Paid”), to our NEOs and the Company’s TSR over the five most recently completed fiscal years.
22965
        
Compensation Actually Paid vs. Net Income
The following chart sets forth the relationship between Compensation Actually Paid to our NEOs and our net income during the five most recently completed fiscal years. While we are required to disclosure our net income (loss) for each covered fiscal year, this is not a metric used in our compensation programs at this time.
23399
        
Total Shareholder Return Vs Peer Group
The following graph compares the cumulative TSR of Recursion, the Nasdaq Biotechnology Index from our April 16, 2021 closing stock price (the date on which our Class A common stock first began trading on the Nasdaq Global Select Market) through December 31, 2025. This graph assumes $100 was invested and the reinvestment of dividends, if any. The comparisons shown in the graph below are based upon historical data and are not necessarily indicative of future performance.
23944
        
Total Shareholder Return Amount $ 13.07 21.60 31.50 24.63 54.73
Peer Group Total Shareholder Return Amount 122.97 92.16 92.69 88.62 98.60
Net Income (Loss) $ (644,759,000) $ (463,661,000) $ (328,066,000) $ (239,476,000) $ (186,479,000)
PEO Name 1.Christopher Gibson        
Additional 402(v) Disclosure Total shareholder return (“TSR”) is calculated assuming $100 was invested in the Company’s Class A common stock or the stock represented by the peer group (as applicable) for the period starting April 16, 2021 (the date on which our common stock first began trading on the Nasdaq Global Select Market) through the end of the listed fiscal year, respectively. The comparisons shown in the graph below are based upon historical data and are not necessarily indicative of future performance.The dollar amounts reported in this column represent the net income (loss) as reported in the Company’s audited financial statements for the applicable year.
The Company does not directly tie any incentive compensation paid to the Company’s Named Executive Officers to any financial performance measures.
All information provided above under the “Pay Versus Performance” heading will not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing, except to the extent the Company specifically incorporates such information by reference.
        
PEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ (8,655,000)        
PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 3,676,389        
PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (1,939,821)        
PEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 1,265,784        
PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (478,659)        
PEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0        
Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (2,511,298)        
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 1,244,324        
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (2,384,494)        
Non-PEO NEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 351,650        
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (557,619)        
Non-PEO NEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ 0